0000950172-24-000249.txt : 20240506
0000950172-24-000249.hdr.sgml : 20240506
20240506171729
ACCESSION NUMBER: 0000950172-24-000249
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240506
FILED AS OF DATE: 20240506
DATE AS OF CHANGE: 20240506
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Virsik Peter
CENTRAL INDEX KEY: 0001826322
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37410
FILM NUMBER: 24918632
MAIL ADDRESS:
STREET 1: 131 ESCANYO WAY
CITY: PORTOLA VALLEY
STATE: CA
ZIP: 94028
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ESSA Pharma Inc.
CENTRAL INDEX KEY: 0001633932
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: SUITE 720
STREET 2: 999 WEST BROADWAY
CITY: VANCOUVER
STATE: A1
ZIP: V5Z 1K5
BUSINESS PHONE: (778) 331-0962
MAIL ADDRESS:
STREET 1: SUITE 720
STREET 2: 999 WEST BROADWAY
CITY: VANCOUVER
STATE: A1
ZIP: V5Z 1K5
4
1
form4.xml
X0508
4
2024-05-06
0001633932
ESSA Pharma Inc.
EPIX
0001826322
Virsik Peter
C/O ESSA PHARMA INC.
999 WEST BROADWAY, SUITE 720
VANCOUVER
A1
V5Z 1K5
BRITISH COLUMBIA, CANADA
true
Chief Operating Officer
true
Common Shares
2024-05-06
4
S
0
694
6.95
D
11246
D
The amount reflects the sale of shares pursuant to Mr. Virsik's 10b5-1 trading plan. The Rule 10b5-1 trading plan was entered into on August 31, 2023.
The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
/s/ Peter Virsik
2024-05-06